DEUTSCHE BANK AG\ - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 113 filers reported holding ASSERTIO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$13,000
-82.9%
20,092
-67.6%
0.00%
Q4 2019$76,000
-74.8%
61,919
-73.9%
0.00%
Q3 2019$302,000
-86.8%
237,227
-64.2%
0.00%
-100.0%
Q2 2019$2,284,000
-53.2%
662,722
-31.2%
0.00%
-66.7%
Q1 2019$4,880,000
+393.4%
962,958
+251.0%
0.00%
+200.0%
Q4 2018$989,000
-91.1%
274,338
-85.4%
0.00%
-66.7%
Q3 2018$11,068,0001,882,6440.00%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 3,278,000$11,834,0000.90%
Senvest Management, LLC 2,124,393$7,669,0000.66%
DELTEC ASSET MANAGEMENT LLC 351,176$1,268,0000.35%
PERKINS CAPITAL MANAGEMENT INC 99,600$360,0000.28%
Matarin Capital Management, LLC 838,619$3,027,415,0000.24%
GLOBEFLEX CAPITAL L P 196,357$709,0000.17%
Opaleye Management Inc. 120,000$433,0000.16%
TSP Capital Management Group, LLC 49,175$178,0000.10%
Spark Investment Management LLC 373,609$1,348,0000.09%
Connor, Clark & Lunn Investment Management Ltd. 3,191,964$11,523,0000.08%
View complete list of ASSERTIO THERAPEUTICS INC shareholders